PCN240 - ALL-COMERS VS. BIOMARKER BASED PATIENT SELECTION FOR BIOTHERAPIES IN ONCOLOGY- IMPACT ON DRUG DEVELOPMENT AND MARKET ACCESS
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.322
https://www.valueinhealthjournal.com/article/S1098-3015(18)33622-2/fulltext
Title :
PCN240 - ALL-COMERS VS. BIOMARKER BASED PATIENT SELECTION FOR BIOTHERAPIES IN ONCOLOGY- IMPACT ON DRUG DEVELOPMENT AND MARKET ACCESS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33622-2&doi=10.1016/j.jval.2018.09.322
First page :
Section Title :
Open access? :
No
Section Order :
2232